Lecoutey, C.; Legay, R.; Davis, A.; Sopková-de Oliveira Santos, J.; Dallemagne, P.; Rochais, C.
Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy. Molecules 2021, 26, 2536.
https://doi.org/10.3390/molecules26092536
AMA Style
Lecoutey C, Legay R, Davis A, Sopková-de Oliveira Santos J, Dallemagne P, Rochais C.
Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy. Molecules. 2021; 26(9):2536.
https://doi.org/10.3390/molecules26092536
Chicago/Turabian Style
Lecoutey, Cédric, Rémi Legay, Audrey Davis, Jana Sopková-de Oliveira Santos, Patrick Dallemagne, and Christophe Rochais.
2021. "Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy" Molecules 26, no. 9: 2536.
https://doi.org/10.3390/molecules26092536
APA Style
Lecoutey, C., Legay, R., Davis, A., Sopková-de Oliveira Santos, J., Dallemagne, P., & Rochais, C.
(2021). Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy. Molecules, 26(9), 2536.
https://doi.org/10.3390/molecules26092536